secwatch.observer — SEC 8-K summary
======================================

Issuer:     C4 Therapeutics, Inc. (CCCC)
CIK:        0001662579
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001628280-24-029301
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

C4 Therapeutics stockholders elect three Class I directors, approve say-on-pay, ratify KPMG
--------------------------------------------------------------------------------

- Kenneth Anderson re-elected with 38.0M for, 8.6M withheld; Laura Bessen with 37.7M for, 8.8M withheld; Owen Hughes with 27.5M for, 19.1M withheld.
- Advisory say-on-pay passed: 34.5M for, 11.9M against, 0.1M abstain.
- KPMG LLP ratified as independent auditor for FY2024: 54.4M for, 0.2M against, 0 abstain.
- No other matters were voted on at the annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662579/000162828024029301/0001628280-24-029301-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662579/000162828024029301/cccc-20240621.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-029301

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer